Measuring temporal response properties of auditory nerve fibers in cochlear implant recipients.


Journal

Hearing research
ISSN: 1878-5891
Titre abrégé: Hear Res
Pays: Netherlands
ID NLM: 7900445

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 31 03 2019
revised: 25 06 2019
accepted: 06 07 2019
pubmed: 22 7 2019
medline: 5 1 2021
entrez: 21 7 2019
Statut: ppublish

Résumé

Auditory nerve fibers' (ANFs) refractoriness and facilitation can be quantified in electrically evoked compound action potentials (ECAPs) recorded via neural response telemetry (NRT). Although facilitation has been observed in animals and human cochlear implant (CI) recipients, no study has modeled this in human CI users until now. In this study, recovery and facilitation effects at different masker and probe levels for three test electrodes (E6, E12 and E18) in 11 CI subjects were recorded. The ECAP recovery and facilitation were modeled by exponential functions and the same function used for +10 CL masker offset condition can be applied to all other masker offsets measurements. Goodness of fit was evaluated for the exponential functions. A significant effect of probe level was observed on a recovery time constant which highlights the importance of recording the recovery function at the maximum acceptable stimulus level. Facilitation time constant and amplitude showed no dependency on the probe level. However, facilitation was stronger for masker level at or around the threshold of the ECAP (T-ECAP). There was a positive correlation between facilitation magnitude and amplitude growth function (AGF) slope, which indicates that CI subjects with better peripheral neural survival have stronger facilitation.

Identifiants

pubmed: 31325737
pii: S0378-5955(19)30142-X
doi: 10.1016/j.heares.2019.07.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-196

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Sonia Tabibi (S)

Department of Information Technology and Electrical Engineering, ETH Zürich (ETHZ), Zürich, Switzerland; Laboratory of Experimental Audiology, ENT Department, University Hospital and University of Zürich, Zürich, Switzerland. Electronic address: sonia.tabibi@usz.ch.

Andrea Kegel (A)

Laboratory of Experimental Audiology, ENT Department, University Hospital and University of Zürich, Zürich, Switzerland.

Wai Kong Lai (WK)

Sydney Cochlear Implant Center, RIDBC, Sydney, Australia.

Ian C Bruce (IC)

Department of Electrical and Computer Engineering, McMaster University, Hamilton, ON, Canada.

Norbert Dillier (N)

Laboratory of Experimental Audiology, ENT Department, University Hospital and University of Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH